Cargando…
Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity
BACKGROUND: Dilated cardiomyopathy (DCM) is a severe, non-ischemic heart disease which ultimately results in heart failure (HF). Decades of research on DCM have revealed diverse aetiologies. Among them, familial DCM is the major form of DCM, with pathogenic variants in LMNA being the second most com...
Autores principales: | Tan, Chia Yee, Chan, Pui Shi, Tan, Hansen, Tan, Sung Wei, Lee, Chang Jie Mick, Wang, Jiong-Wei, Ye, Shu, Werner, Hendrikje, Loh, Ying Jie, Lee, Yin Loon, Ackers-Johnson, Matthew, Foo, Roger S. Y., Jiang, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577912/ https://www.ncbi.nlm.nih.gov/pubmed/37840136 http://dx.doi.org/10.1186/s12967-023-04542-4 |
Ejemplares similares
-
LMNA-related dilated cardiomyopathy
por: Vaikhanskaya, Tatiyana, et al.
Publicado: (2014) -
Upregulation of Yy1 Suppresses Dilated Cardiomyopathy caused by Ttn insufficiency
por: Liao, Dan, et al.
Publicado: (2019) -
Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy
por: Zhang, Xiaolin, et al.
Publicado: (2021) -
Activation of PDGF Pathway Links LMNA Mutation to Dilated Cardiomyopathy
por: Lee, Jaecheol, et al.
Publicado: (2019) -
Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses
por: Zhou, Honghua, et al.
Publicado: (2020)